Clinical Trials in Croatia

• Phase 3 Study of Telitacicept in Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2) Not authorised
  2024-512716-21-00 Phase III Moderately to Severely Active Systemic Lupus Erythematosus Remegen Co. Ltd.
• Impact of time of alpelisib administration, concomitant fasting and low carbohydrate diet on alpelisib toxicity and efficacy; a pilot random… Not authorised
  2025-521008-22-00 Phase II metasatic breast cancer, hormon positive, her 2 negative Croatian Cooperative Group For Clinical Trial Research In Oncology
• A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Unknown
  2022-502779-40-99 Phase III Primary prevention of atherosclerotic cardiovascular disease… Novartis Pharma AG
• A clinical study of MK-7240 for the treatment of ulcerative colitis (MK-7240-001) Unknown
  2025-523766-25-00 Phase III Ulcerative colitis Merck Sharp & Dohme LLC
• DALY II USA/MB-CART2019.1 for DLBCL Pending
  2023-508508-39-01 Phase II Relapsed/refractory diffuse large B cell lymphoma (R-R DLBCL… Miltenyi Biomedicine GmbH
• A Randomized, Multiple-Dose, Open-Label, Parallel-Group Study to Evaluate the Pharmacokinetic Profiles of LY03010 and the Relative Bioavaila… Pending
  2023-508981-13-00 Schizophrenia Geneora Pharma (Shijiazhuang) Co. Ltd.
• A research study on how well cagrilintide and CagriSema work in children and adolescents with excess body weight Pending
  2023-509176-42-00 Phase III/IV Obesity and T2D Novo Nordisk A/S
• ALLIC 2022 international clinical investigation for advanced management of childhood acute lymphoblastic leukemia Pending
  2024-513824-41-00 Phase IV Childhood non-mature-B Acute Lymphoblastic Leukemia Semmelweis University
• A clinical trial to learn about the long-term safety of FUB523 (zigakibart) in people with immunoglobulin A (IgA) nephropathy who have compl… Pending
  2024-519638-22-00 Phase III IgA nephropathy Novartis Pharma AG
• Extension Study of ADX-324 in Hereditary angioedema Pending
  2025-521353-16-00 Phase III Hereditary Angioedema Adarx Pharmaceuticals Inc.
• Study of Nemolizumab for the treatment of adults with systemic sclerosis Pending
  2025-522294-11-00 Phase II Systemic sclerosis Galderma S.A.
• A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with psoriatic arthritis (P… Pending
  2025-522471-28-00 Phase III psoriatic arthritis (PsA) MoonLake Immunotherapeutics AG
• A Phase 3, Long-Term Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of Zasocitinib in Subjects with Active Pso… Pending
  2025-522586-30-00 Phase III Psoriatic Arthritis Takeda Development Center Americas Inc.
• A study of BV100 plus low dose polymyxin B for treating hospital -acquired and ventilator-associated pneumonia caused by antibiotic resistan… Pending
  2025-524092-23-00 Phase III Hospital-acquired bacterial pneumonia including ventilator-a… Bioversys S.A.S.
• A Phase 3 Study of Orelabrutinib in Non-active Secondary Progressive Multiple Sclerosis Pending
  2025-524322-18-00 Phase III Non-active Secondary Progressive Multiple Sclerosis (SPMS) Zenas Biopharma (USA) LLC
• Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combination for Inflammatory Bowel Disease Pending
  2025-524640-35-00 Phase II Ulcerative colitis (Inflammatory Bowel Disease) Spyre Therapeutics Inc.
• A study of LY4268989 in participants with Moderately to Severely Active Ulcerative Colitis (EMERALD-3) Recruiting
  2025-524404-29-00 Phase II Ulcerative Colitis, Active Moderate Eli Lilly & Co.
• A clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003) Recruiting
  2025-524894-17-00 Phase II/III Neovascular age-related macular degeneration (NVAMD) Eyebiotech Limited
• A Phase 3 Study of Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis Recruiting
  2025-524316-11-00 Phase III Primary Progressive Multiple Sclerosis (PPMS) Zenas Biopharma (USA) LLC
• A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma (SOLAIRIA-1) Recruiting
  2025-521950-41-00 Phase III severe uncontrolled asthma Generate Biomedicines Inc.
• PODOMOUNT-Basket, a study to test whether BI 764198 helps adults and adolescents with different types of kidney disease Recruiting
  2025-523425-17-00 Phase II Proteinuric kidney diseases Boehringer Ingelheim Espana S.A.; Boehringer Ingelheim International GmbH
• A study to test whether different doses of BI 3000202 help people with systemic lupus erythematosus (SLE) Recruiting
  2025-523488-39-00 Phase II Systemic lupus erythematosus Boehringer Ingelheim Espana S.A.; Boehringer Ingelheim International GmbH
• Open-label Extension of KarXT + KarX-EC for Agitation in Alzheimer’s Disease Recruiting
  2024-519994-20-00 Phase III Agitation Associated with Alzheimer’s Disease Bristol-Myers Squibb Services Unlimited Company
• AMAZE 8: A research study investigating how well the medicine NNC0487-0111 compared to semaglutide helps people with excess body weight and … Recruiting
  2024-520446-31-00 Phase III Participants with overweight or obesity, and type 2 diabetes Novo Nordisk A/S

Showing 1–24 of 276 trials